Boston researchers have found that less than 10% of retrievable IVC filters were removed from patients, despite the fact that the indication for the filter placement was no longer present at discharge.
Cardio
CardioMEMS Trial: Device “Incredibly Compelling” But Concerns About Bias.
CardioMEMS nurse interventions thought by FDA panel to have introduced bias to randomised trial.
Two New Products From Boston Scientific
Boston Scientific launchea CHARGER™ PTA Balloon catheter in USA and Infinion 16, first and only 16-contact percutaneous lead for treatment of patients suffering chronic pain.
CardioMEMS Device Safe According To FDA Panel, But Effectiveness Questioned.
A U.S.FDA panel has decided not to recommend CardioMEMS implantable heart device for treating heart failure because supporting clinical research may have been biased by human intervention.
Abbott Trials Absorb™ Bioresorbable Vascular Scaffold Against Metallic Drug Eluting Stent
Abbott today announced the initiation of ABSORB II, the first randomized, controlled, multi-center clinical trial to evaluate the safety, efficacy and performance of the Absorb™ bioresorbable vascular scaffold (BVS) compared to the company’s XIENCE PRIME™ Everolimus Eluting Coronary Stent System.
Are You Carrying Your Pacemaker Donor Card?
Reusing Pacemakers from deceased donors is safe and effective, study finds.
Report Suggests Orthopods Like Ortho Companies, While Cardiologists Don’t Like Cardiology Companies
Details of how differing specialties make Medical Device purchase decisions have been quantified in Millennium Research Group’s new Perception Pulse Report
Pulling The Plug On Grandma In Election Year?
The news that US Medicare was demanding pre-approval of hospital stays in 11 states was exposed as ill-informed with consequent recovery of MedTech share prices.
CE Mark For Sorin’s New Oxygenator
Sorin Group has received CE Mark approval for INSPIRE™6, the first model of an entire new family of oxygenator systems bringing improved performance and flexibility during cardiopulmonary bypass procedures in adult patients.
AtriCure Aiming At Thoracoscopic Indication For AtriClip LAA Occlusion Device
MedCity News has reported on AtriCure’s quest to gain approval for use of the device in a minimally invasive fashion in stand-alone procedures to close the LAA.
European Clot Management Device Market To Grow To $200 Million By 2016
Most Significant Growth In Clot Management Market Will Be in Mechanical Thrombectomy Procedures, According to Millennium Research Group.
Hospital Defibrillators: AHA Admits Old Models Outperform New
When the rush to new technology may need more consideration: How the American Heart Association may have to resuscitate its policy on defibrillators.
Texas “Overstenting” Case Close To Resolution
Texas Cardiologist Dr Samuel DeMaio now only has one of his eight original complaints unresolved and has emerged with no restrictions to his licence.
Aptus HeliFX EndoStapling System Cleared By FDA
Aptus HeliFX Endograft Fixation Device follows May CE Mark with FDA approval.
First UK patients receive MRI-compatible pacemaker
Medtech Business has reported that a cardiac pacing system designed for safe use during magnetic resonance imaging (MRI) scans has been implanted in UK patients for the first time.
First Patient In The Svelte DIRECT Drug-Eluting Stent Study
SvelteMedical Systems Announces Treatment of First Patient in the DIRECT Drug-Eluting Stent Study.